Cellectar Biosciences Statistics
NASDAQ: CLRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.44-0.075 (-4.97%)
Market open · Delayed 15 min · as of Oct 8, 10:07 AM ET
Cellectar Biosciences by the numbers
Cellectar Biosciences has a market capitalization of $13.6 million based on 9.45M shares outstanding. With trailing EPS of $-3.46, Cellectar Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 38.5% below its 50-day average and 48.6% below its 200-day average.
Average daily trading volume is 61.52K shares, or about $88,277 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CLRB valuation vs. peer median
| Metric | CLRB | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.56M | $14.04M | -3% |
| Avg. volume | 61.52K | 544.76K | -89% |
Peer median across 8 companies: TVRD, HIND, KPTI, BFRI, BFRG, CTXR, AEON, DARE.
Valuation
- Market cap
- $13.56M
- EPS (TTM)
- $-3.46
- Shares outstanding
- 9.45M
Price and trading
- Previous close
- 1.51
- Open
- 1.51
- Day range
- 1.44 – 1.53
- 52-week range
- 1.44 – 5.07
- 52-week change
- -70.57%
- Beta
- —
- Volume
- 12.45K
- Average volume
- 61.52K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 13, 2026
Additional statistics
- Market Cap
- 13.56M
- Forward Pe
- -0.75
- Eps
- -3.46
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.07
- Week52 Low
- 1.44
- Avg Volume
- 61,517.00
- Shares Outstanding
- 9.45M
- Ma50
- 2.33
- Ma200
- 2.79
- Earnings Date
- Aug 13, 2026
- Pct From52w High
- -71.70%
- Pct From52w Low
- 0.00%